Wales-based medical device business, IQ Endoscopes has strengthened its position for supporting clinicians and patients across the UK in 2025 and beyond, following its latest multi-million funding round from BGF and the Development Bank of Wales. The deal was advised on by GS Verde Group.

The funding will enable IQ Endoscopes to accelerate the roll-out of its sustainable single-use endoscopy platform. Designed and built in the UK, the platform is devised to increase the capacity of endoscopy provision across the country, allowing patients to be diagnosed earlier and ultimately help people live longer, healthier lives.

Of the 70 million endoscopy procedures currently completed each year, 98% are performed with reusable devices. These require reprocessing after each use, which is both costly and time intensive, as well as having a significant environmental impact and posing the risk of cross contamination.

The need for innovation in diagnostic healthcare has never been greater. According to Cancer Research, NHS England aims to begin treatment for 85% of cancer patients within 62 days of an urgent referral; a target that hasn't been met since 2015. Worst still, the number of new cancer cases worldwide is expected to increase to 28 million per year by 2040, a 54.9% increase from 2020.

In addition, the UK is suffering from a shortage of trained and skilled endoscopists, leading to increased waiting times for patients and rising costs for the NHS.

In response, IQ Endoscopes' innovative product is set to launch into an initial four health centres this July to begin to tackle the backlog of patients needing endoscopy treatments across England and Wales.

Matt Ginn, IQ Endoscopes CEO said: "At IQ Endoscopes, we are on a mission to help drive rapid early diagnosis using our single-use endoscopes to help people live a longer and better life. This funding round has brought that ambition one step closer to reality and we are exceptionally thankful to BGF, DBW and early shareholders for their ongoing belief in our mission. With strong evidence supporting the clinical acceptance of our technology, a clear path to regulatory clearance and the required manufacturing capability established, we are primed for early commercialisation of our technology in the UK from July 2025."

IQ Endoscopes' model of flexible, plug-and-play endoscopes strongly aligns with the UK Government's proposed network of Community Diagnostic Centres, designed to make procedures such as endoscopies more accessible in local areas. By offering greater flexibility, choice, and control, IQ Endoscopes can empower clinicians to increase capacity and deliver faster, more efficient care to patients - enabling rapid diagnosis and treatment.

Matt Sutton, Director at GS Verde Group, said: "GS Verde Group are pleased to have supported IQ Endoscopes in securing the vital funding needed to strengthen its innovative healthcare solutions and its position in the market. We look forward to seeing IQ Endoscopes' continued success following this transition of growth."

Tom Davies, Investor for the Technologies Venture Investments team Development Bank of Wales said: "This is the fourth investment we have made into IQ Endoscopes since our initial seed investment in the summer of 2020, and we continue to be impressed by their growth and innovation as a leading Welsh MedTech company, delivering essential single-use solutions in the field of endoscopy."

The GS Verde Group are business-focused experts in getting deals done. Combining all the services needed to complete a corporate transaction, including legal, corporate finance, tax, accountancy and communications, GS Verde Group acts as a complete advisory team and provides a truly end-to-end service.